Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
NIVM On Other Exchanges
Symbol
Exchange
OTC US
As of 4:30 PM 03/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur D. Emil Esq.

AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 2 different industries.

See Board Relationships
87--

Background*

Mr. Arthur D. Emil, Esq., has been a practicing attorney in New York City for over forty years, including with Cohen Tauber Spievack & Wagner since 2003. Mr. Emil is the founding principal of two real estate development firms with commercial, residential and mixed-use properties in Connecticut, New York and Ohio. He was of counsel to Kramer, Levin, Naftalis & Frankel in New York City ("Kramer Levin") from 1994 to 2002. Between 1986 and 1993, he was a Senior Partner of ...

Read Full Background

Corporate Headquarters*

485 Metro Place South
Dublin, Ohio 43017

United States

Phone: 614-923-8822
Fax: 614-923-5242

Board Members Memberships*

1995-N/A
Former Director
2003-2009
Former Director, Chairman of Corporate Governance/Nominating Committee, Member of Audit Committee, Member of Executive Compensation Committee and Member of Finance Committee
2005-N/A
Former Director and Member of Executive Committee
2005-Present
Director

Education*

Unknown/Other Education 1950
Columbia University
LLB
Columbia University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NIVM:US $0.02 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NATIONAL INVESTMENT MANAGERS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.